Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study.

    Sep 2, 2026DOI: 10.1093/cid/ciag165Journal ArticleCID

    Written by: Abhishek DeshpandeRebecca SchulteRamara E WalkerAndrea M PallottaMing WangSameer S KadriSarah HaesslerMichael KlompasPeter K LindenauerMichael B Rothberg

    Find these authors on Roon

    MK
    Dr. Michael Klompas
    General ID · BWH

    Summary

    BACKGROUND: Procalcitonin (PCT) testing may guide antibiotic decisions in community-acquired pneumonia (CAP), but real-world evidence of its impact on antibiotic prescribing in the era of shorter antibiotic courses remains limited.METHODS: We conducted a retrospective cohort study of adults with CAP admitted to the wards of 12 hospitals between November 2022 and January 2025. Primary analyses included: (1) PCT testing rates at admission, (2) the association between PCT testing and duration of antibiotic therapy, and (3) among patients initiated on extended-spectrum antibiotics (ESAs), the relationship between PCT results and early de-escalation. We compared outcomes between PCT-tested and untested patients and between those with low (<0.1 μg/L) vs high (≥0.1 μg/L) PCT values using propensity score overlap weighting to control for potential confounders.RESULTS: Among 17 290 non-intensive care unit (ICU) admissions for CAP, PCT testing was performed for 10 658 patients (59.5%) within 24 hours of admission. After adjustments, PCT testing was associated with shorter antibiotic duration (adjusted mean difference, -0.32 days; 95% confidence interval [CI], -.52 to -.12) but was not significantly associated with ESA de-escalation compared with no PCT testing (hazard ratio, 1.05; 95% CI, .99-1.12). Patients with low PCT values received shorter antibiotic courses compared with those with high values (adjusted mean difference, -0.56 days; 95% CI, -.85 to -.49).CONCLUSIONS: In non-ICU patients with CAP, PCT testing was associated with modest differences in antibiotic duration, primarily when values were low.
    MK

    Dr. Michael Klompas

    Infectious Disease · General Infectious Disease
    Brigham and Women's Hospital
    michaelklompas